Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...

Breakthrough Nanotech Formula Combats Inflammation, Strengthens Nails, and Revitalizes Skin with Scientifically Proven ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Apotex has launched the first generic version of Tasigna (nilotinib), a TKI used to treat adult and pediatric patients with Ph+ CML.

Eli Lilly said yesterday that it will acquire SiteOne Therapeutics, a biotech developing non-opioid pain drugs, for up to $1 ...